Vergent Bioscience Alternatives & Competitors
12 companies similar to Vergent Bioscience — Illuminate the path to precise cancer surgery with advanced imaging that disting...
Companies similar to Vergent Bioscience
Great Robotics
An innovative surgical robot company. Our research for improving human health has no limit...
Sirius Medical
Moving from localization to Surgical Marker Navigation
Brain Navi Biotechnology Co., Ltd.
Brain Navi innovates surgical robots that provide precision and safety for surgery/neurosu...
Interventional Systems
Steering your path towards micro-invasive procedures.
Rival Readout
Competing with Vergent Bioscience? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Centerline Biomedical
A New Way to Envision Interventional Navigation
Galil Medical Ltd.
Cryoablation of cancerous tumors and Cryosurgery
BoomRay Pharmaceuticals
成为国际一流、品质卓越的放射性药物公司 Global pioneer in radiopharmaceuticals and commitme...
New View Surgical, Inc.
Redefining and Simplifying Laparoscopic Surgery
Aurora Oncology
Pioneering targeted therapeutics to combat non-muscle invasive bladder cancer with precisi...
ViewRay, Inc.
Conquer cancer by re-envisioning radiation therapy.
Scinvivo B.V.
Optical biopsy for bladder cancer diagnostics
FluoGuide A/S
Intelligent surgical targeting - light up cancer and increase surgical precision
About Vergent Bioscience
Vergent Bioscience is positioned at the forefront of surgical oncology innovation, founded in 2016 and focused on revolutionizing cancer surgery through advanced imaging technology. Their flagship product, VGT-309, is a proprietary molecularly-targeted imaging molecule that distinguishes cancerous tissue from normal ti...
Development of VGT-309 for tumor visualization, Real-time surgical imaging, Research on optimizing surgical treatments
Surgeons, Hospitals performing cancer surgeries, Cancer treatment centers
Cancer Surgery, Advanced Imaging, Molecularly-targeted Imaging, VGT-309, Fluorescent Dye, Tumor Visualization, Surgical Oncology, Minimally Invasive Surgery, Robotic Surgery, Value-based Healthcare, Enzyme Targeting, Cancer Diagnostics, Surgical Guidance, Oncology Innovation, Precision Medicine
B2B, B2B2C
Product Sales, Usage Based, Value Based Pricing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Vergent Bioscience: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Vergent Bioscience on 4 Apr 2026. The 12 companies listed here were last checked between 22 Jun 2024 and 4 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.